Membrane transfer from tumor cells overcomes deficient phagocytic ability of plasmacytoid dendritic cells for the acquisition and presentation of tumor antigens

Journal of Immunology

Volumn 192, Issue 2, 2014, Pages 824-832

  Bonaccorsi, Irene ^a,b   Morandi, Barbara ^c   Antsiferova, Olga ^d   Costa, Gregorio ^a,b   Oliveri, Daniela ^a,b   Conte, Romana ^e   Pezzino, Gaetana ^a,b   Vermiglio, Giovanna ^a   Anastasi, Giuseppe Pio ^a   Navarra, Giuseppe ^a   Münz, Christian ^d   Carlo, Emma Di ^f   Mingari, Maria Cristina ^c,e   Ferlazzo, Guido ^a,b  

^a UNIVERSITY OF MESSINA   (Italy)

^b UNIVERSITY OF MESSINA   (Italy)

^c UNIVERSITY OF GENOA   (Italy)

^d UNIVERSITY OF ZURICH   (Switzerland)

^e UNIVERSITY OF GENOA   (Italy)

^f UNIVERSITY OF CHIETI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

EPITHELIAL CELL ADHESION MOLECULE; TUMOR ANTIGEN;

ANIMAL TISSUE; ANTIGEN PRESENTATION; ARTICLE; CANCER TISSUE; CD8+ T LYMPHOCYTE; CELL CONTACT; CELL ISOLATION; CELL MEMBRANE TRANSPORT; COLON CANCER; CONTROLLED STUDY; HLA SYSTEM; HUMAN; HUMAN CELL; IN VIVO STUDY; INTERNALIZATION; NONHUMAN; PHAGOCYTOSIS; PLASMACYTOID DENDRITIC CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR CELL;

ANTIGEN PRESENTATION; ANTIGENS, NEOPLASM; CACO-2 CELLS; CD8-POSITIVE T-LYMPHOCYTES; CELL ADHESION MOLECULES; CELL LINE; CELL LINE, TUMOR; CELL MEMBRANE; DENDRITIC CELLS; EPITHELIAL CELLS; HUMANS; INTERLEUKIN-3; K562 CELLS; MAJOR HISTOCOMPATIBILITY COMPLEX; MCF-7 CELLS; PHAGOCYTOSIS; U937 CELLS;

EID: 84892742068     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1301039     Document Type: Article

References (53)

1. Banchereau, J., and A. K. Palucka. 2005. Dendritic cells as therapeutic vaccines against cancer. Nat. Rev. Immunol. 5: 296-306. (Pubitemid 40516155)
2. Bevan, M. J. 2006. Cross-priming. Nat. Immunol. 7: 363-365.
3. Dolan, B. P., K. D. Gibbs, Jr., and S. Ostrand-Rosenberg. 2006. Dendritic cells cross-dressed with peptide MHC class I complexes prime CD8+ T cells. J. Immunol. 177: 6018-6024. (Pubitemid 44628815)
4. Viret, C., A. K. Barlow, and C. A. Janeway, Jr. 1999. On the intrathymic intercellular transfer of self-determinants. Immunol. Today 20: 8-10. (Pubitemid 29136542)
5. Russo, V., D. Zhou, C. Sartirana, P. Rovere, A. Villa, S. Rossini, C. Traversari, and C. Bordignon. 2000. Acquisition of intact allogeneic human leukocyte antigen molecules by human dendritic cells. Blood 95: 3473-3477. (Pubitemid 30428479)
6. Dolan, B. P., K. D. Gibbs, Jr., and S. Ostrand-Rosenberg. 2006. Tumor-specific CD4+ T cells are activated by "cross-dressed" dendritic cells presenting peptide-MHC class II complexes acquired from cell-based cancer vaccines. J. Immunol. 176: 1447-1455. (Pubitemid 43134287)
7. Qu, C., V. A. Nguyen, M. Merad, and G. J. Randolph. 2009. MHC class I/peptide transfer between dendritic cells overcomes poor cross-presentation by monocytederived APCs that engulf dying cells. J. Immunol. 182: 3650-3659.
8. Wakim, L. M., and M. J. Bevan. 2011. Cross-dressed dendritic cells drive memory CD8+ T-cell activation after viral infection. Nature 471: 629-632.
9. Li, L., S. Kim, J. M. Herndon, P. Goedegebuure, B. A. Belt, A. T. Satpathy, T. P. Fleming, T. H. Hansen, K. M. Murphy, and W. E. Gillanders. 2012. Crossdressed CD8α+/CD103+ dendritic cells prime CD8+ T cells following vaccination. Proc. Natl. Acad. Sci. USA 109: 12716-12721.
10. Yewdell, J. W., and S. M. Haeryfar. 2005. Understanding presentation of viral antigens to CD8+ T cells in vivo: the key to rational vaccine design. Annu. Rev. Immunol. 23: 651-682. (Pubitemid 40563182)
11. Colonna, M., G. Trinchieri, and Y. J. Liu. 2004. Plasmacytoid dendritic cells in immunity. Nat. Immunol. 5: 1219-1226. (Pubitemid 41057736)
12. Colonna, M., and M. Cella. 2007. Crosspresentation: plasmacytoid dendritic cells are in the business. Immunity 27: 419-421. (Pubitemid 47418673)
13. Villadangos, J. A., and L. Young. 2008. Antigen-presentation properties of plasmacytoid dendritic cells. Immunity 29: 352-361.
14. Dalgaard, J., K. J. Beckstrøm, F. L. Jahnsen, and J. E. Brinchmann. 2005. Differential capability for phagocytosis of apoptotic and necrotic leukemia cells by human peripheral blood dendritic cell subsets. J. Leukoc. Biol. 77: 689-698. (Pubitemid 40628749)
15. Grouard, G., M. C. Rissoan, L. Filgueira, I. Durand, J. Banchereau, and Y. J. Liu. 1997. The enigmatic plasmacytoid T cells develop into dendritic cells with interleukin (IL)-3 and CD40-ligand. J. Exp. Med. 185: 1101-1111. (Pubitemid 27136802)
16. Stent, G., J. C. Reece, D. C. Baylis, K. Ivinson, G. Paukovics, M. Thomson, and P. U. Cameron. 2002. Heterogeneity of freshly isolated human tonsil dendritic cells demonstrated by intracellular markers, phagocytosis, and membrane dye transfer. Cytometry 48: 167-176. (Pubitemid 34753631)
17. Piccioli, D., C. Sammicheli, S. Tavarini, S. Nuti, E. Frigimelica, A. G. Manetti, A. Nuccitelli, S. Aprea, S. Valentini, E. Borgogni, et al. 2009. Human plasmacytoid dendritic cells are unresponsive to bacterial stimulation and require a novel type of cooperation with myeloid dendritic cells for maturation. Blood 113: 4232-4239.
18. Hoeffel, G., A. C. Ripoche, D. Matheoud, M. Nascimbeni, N. Escriou, P. Lebon, F. Heshmati, J. G. Guillet, M. Gannagé, S. Caillat-Zucman, et al. 2007. Antigen crosspresentation by human plasmacytoid dendritic cells. Immunity 27: 481-492. (Pubitemid 47418679)
19. Ochando, J. C., C. Homma, Y. Yang, A. Hidalgo, A. Garin, F. Tacke, V. Angeli, Y. Li, P. Boros, Y. Ding, et al. 2006. Alloantigen-presenting plasmacytoid dendritic cells mediate tolerance to vascularized grafts. Nat. Immunol. 7: 652-662. (Pubitemid 43797347)
20. Tel, J., A. J. Lambeck, L. J. Cruz, P. J. Tacken, I. J. de Vries, and C. G. Figdor. 2010. Human plasmacytoid dendritic cells phagocytose, process, and present exogenous particulate antigen. J. Immunol. 184: 4276-4283.
21. Benitez-Ribas, D., G. J. Adema, G. Winkels, I. S. Klasen, C. J. Punt, C. G. Figdor, and I. J. de Vries. 2006. Plasmacytoid dendritic cells of melanoma patients present exogenous proteins to CD4+ T cells after Fc gamma RIImediated uptake. J. Exp. Med. 203: 1629-1635. (Pubitemid 44036266)
22. Tel, J., D. Benitez-Ribas, S. Hoosemans, A. Cambi, G. J. Adema, C. G. Figdor, P. J. Tacken, and I. J. de Vries. 2011. DEC-205 mediates antigen uptake and presentation by both resting and activated human plasmacytoid dendritic cells. Eur. J. Immunol. 41: 1014-1023.
23. Doyle, A., T. J. Jones, J. L. Bidwell, and B. A. Bradley. 1985. In vitro development of human monoclonal antibody-secreting plasmacytomas. Hum. Immunol. 13: 199-209. (Pubitemid 15040586)
24. Carrega, P., G. Pezzino, P. Queirolo, I. Bonaccorsi, M. Falco, G. Vita, D. Pende, A. Misefari, A. Moretta, M. C. Mingari, et al. 2009. Susceptibility of human melanoma cells to autologous natural killer (NK) cell killing: HLA-related effector mechanisms and role of unlicensed NK cells. PLoS ONE 4: e8132.
25. Subklewe, M., K. Sebelin, A. Block, A. Meier, A. Roukens, C. Paludan, J. F. Fonteneau, R. M. Steinman, and C. Münz. 2005. Dendritic cells expand Epstein Barr virus specific CD8+ T cell responses more efficiently than EBV transformed B cells. Hum. Immunol. 66: 938-949. (Pubitemid 41790529)
26. Ferlazzo, G., A. Wesa, W. Z. Wei, and A. Galy. 1999. Dendritic cells generated either from CD34+ progenitor cells or from monocytes differ in their ability to activate antigen-specific CD8+ T cells. J. Immunol. 163: 3597-3604. (Pubitemid 29450879)
27. Riboldi, E., R. Daniele, C. Parola, A. Inforzato, P. L. Arnold, D. Bosisio, D. H. Fremont, A. Bastone, M. Colonna, and S. Sozzani. 2011. Human C-type lectin domain family 4, member C (CLEC4C/BDCA-2/CD303) is a receptor for asialo-galactosyl-oligosaccharides. J. Biol. Chem. 286: 35329-35333.
28. Nierkens, S., J. Tel, E. Janssen, and G. J. Adema. 2013. Antigen crosspresentation by dendritic cell subsets: one general or all sergeants? Trends Immunol. 34: 361-370.
29. Davis, D. M. 2007. Intercellular transfer of cell-surface proteins is common and can affect many stages of an immune response. Nat. Rev. Immunol. 7: 238-243.
30. Crozat, K., R. Guiton, V. Contreras, V. Feuillet, C. A. Dutertre, E. Ventre, T. P. Vu Manh, T. Baranek, A. K. Storset, J. Marvel, et al. 2010. The XC chemokine receptor 1 is a conserved selective marker of mammalian cells homologous to mouse CD8alpha+ dendritic cells. J. Exp. Med. 207: 1283-1292.
31. Tel, J., G. Schreibelt, S. P. Sittig, T. S. Mathan, S. I. Buschow, L. J. Cruz, A. J. Lambeck, C. G. Figdor, and I. J. de Vries. 2013. Human plasmacytoid dendritic cells efficiently cross-present exogenous Ags to CD8+ T cells despite lower Ag uptake than myeloid dendritic cell subsets. Blood 121: 459-467.
32. Hartmann, E., B. Wollenberg, S. Rothenfusser, M. Wagner, D. Wellisch, B. Mack, T. Giese, O. Gires, S. Endres, and G. Hartmann. 2003. Identification and functional analysis of tumor-infiltrating plasmacytoid dendritic cells in head and neck cancer. Cancer Res. 63: 6478-6487. (Pubitemid 37255200)
33. Schettini, J., and P. Mukherjee. 2008. Physiological role of plasmacytoid dendritic cells and their potential use in cancer immunity. Clin. Dev. Immunol. 2008: 106321.
34. Salio, M., M. Cella, W. Vermi, F. Facchetti, M. J. Palmowski, C. L. Smith, D. Shepherd, M. Colonna, and V. Cerundolo. 2003. Plasmacytoid dendritic cells prime IFN-gamma-secreting melanoma-specific CD8 lymphocytes and are found in primary melanoma lesions. Eur. J. Immunol. 33: 1052-1062. (Pubitemid 36546693)
35. Vermi, W., M. Soncini, L. Melocchi, S. Sozzani, and F. Facchetti. 2011. Plasmacytoid dendritic cells and cancer. J. Leukoc. Biol. 90: 681-690.
36. Zou, W., V. Machelon, A. Coulomb-L'Hermin, J. Borvak, F. Nome, T. Isaeva, S. Wei, R. Krzysiek, I. Durand-Gasselin, A. Gordon, et al. 2001. Stromal-derived factor-1 in human tumors recruits and alters the function of plasmacytoid precursor dendritic cells. Nat. Med. 7: 1339-1346. (Pubitemid 34007939)
37. Treilleux, I., J. Y. Blay, N. Bendriss-Vermare, I. Ray-Coquard, T. Bachelot, J. P. Guastalla, A. Bremond, S. Goddard, J. J. Pin, C. Barthelemy-Dubois, and S. Lebecque. 2004. Dendritic cell infiltration and prognosis of early stage breast cancer. Clin. Cancer Res. 10: 7466-7474. (Pubitemid 39561754)
38. Labidi-Galy, S. I., V. Sisirak, P. Meeus, M. Gobert, I. Treilleux, A. Bajard, J. D. Combes, J. Faget, F. Mithieux, A. Cassignol, et al. 2011. Quantitative and functional alterations of plasmacytoid dendritic cells contribute to immune tolerance in ovarian cancer. Cancer Res. 71: 5423-5434.
39. Sisirak, V., J. Faget, M. Gobert, N. Goutagny, N. Vey, I. Treilleux, S. Renaudineau, G. Poyet, S. I. Labidi-Galy, S. Goddard-Leon, et al. 2012. Impaired IFN-α production by plasmacytoid dendritic cells favors regulatory T-cell expansion that may contribute to breast cancer progression. Cancer Res. 72: 5188-5197.
40. Faget, J., N. Bendriss-Vermare, M. Gobert, I. Durand, D. Olive, C. Biota, T. Bachelot, I. Treilleux, S. Goddard-Leon, E. Lavergne, et al. 2012. ICOSligand expression on plasmacytoid dendritic cells supports breast cancer progression by promoting the accumulation of immunosuppressive CD4+ T cells. Cancer Res. 72: 6130-6141.
41. Gilliet, M., and Y. J. Liu. 2002. Human plasmacytoid-derived dendritic cells and the induction of T-regulatory cells. Hum. Immunol. 63: 1149-1155. (Pubitemid 36025989)
42. Goubier, A., B. Dubois, H. Gheit, G. Joubert, F. Villard-Truc, C. Asselin-Paturel, G. Trinchieri, and D. Kaiserlian. 2008. Plasmacytoid dendritic cells mediate oral tolerance. Immunity 29: 464-475.
43. Ito, T., M. Yang, Y. H. Wang, R. Lande, J. Gregorio, O. A. Perng, X. F. Qin, Y. J. Liu, and M. Gilliet. 2007. Plasmacytoid dendritic cells prime IL-10-producing T regulatory cells by inducible costimulator ligand. J. Exp. Med. 204: 105-115. (Pubitemid 46148761)
44. Sharma, M. D., B. Baban, P. Chandler, D. Y. Hou, N. Singh, H. Yagita, M. Azuma, B. R. Blazar, A. L. Mellor, and D. H. Munn. 2007. Plasmacytoid dendritic cells from mouse tumor-draining lymph nodes directly activate mature Tregs via indoleamine 2,3-dioxygenase. J. Clin. Invest. 117: 2570-2582. (Pubitemid 47494358)
45. Conrad, C., J. Gregorio, Y. H. Wang, T. Ito, S. Meller, S. Hanabuchi, S. Anderson, N. Atkinson, P. T. Ramirez, Y. J. Liu, et al. 2012. Plasmacytoid dendritic cells promote immunosuppression in ovarian cancer via ICOS costimulation of Foxp3(+) T-regulatory cells. Cancer Res. 72: 5240-5249.
46. Hadeiba, H., K. Lahl, A. Edalati, C. Oderup, A. Habtezion, R. Pachynski, L. Nguyen, A. Ghodsi, S. Adler, and E. C. Butcher. 2012. Plasmacytoid dendritic cells transport peripheral antigens to the thymus to promote central tolerance. Immunity 36: 438-450.
47. Mouriès, J., G. Moron, G. Schlecht, N. Escriou, G. Dadaglio, and C. Leclerc. 2008. Plasmacytoid dendritic cells efficiently cross-prime naive T cells in vivo after TLR activation. Blood 112: 3713-3722.
48. Kim, R., M. Emi, K. Tanabe, and K. Arihiro. 2007. Potential functional role of plasmacytoid dendritic cells in cancer immunity. Immunology 121: 149-157. (Pubitemid 46663098)
49. Molenkamp, B. G., P. A. van Leeuwen, S. Meijer, B. J. Sluijter, P. G. Wijnands, A. Baars, A. J. van den Eertwegh, R. J. Scheper, and T. D. de Gruijl. 2007. Intradermal CpG-B activates both plasmacytoid and myeloid dendritic cells in the sentinel lymph node of melanoma patients. Clin. Cancer Res. 13: 2961-2969. (Pubitemid 46849571)
50. Pashenkov, M., G. Goëss, C. Wagner, M. Hörmann, T. Jandl, A. Moser, C. M. Britten, J. Smolle, S. Koller, C. Mauch, et al. 2006. Phase II trial of a tolllike receptor 9-activating oligonucleotide in patients with metastatic melanoma. J. Clin. Oncol. 24: 5716-5724. (Pubitemid 46631314)
51. Pascale, F., V. Contreras, M. Bonneau, A. Courbet, S. Chilmonczyk, C. Bevilacqua, M. Epardaud, V. Niborski, S. Riffault, A. M. Balazuc, et al. 2008. Plasmacytoid dendritic cells migrate in afferent skin lymph. J. Immunol. 180: 5963-5972.
52. Published erratum appears in 2008 J. Immunol. 180: 8470.
53. Josefowicz, S. Z., L. F. Lu, and A. Y. Rudensky. 2012. Regulatory T cells: mechanisms of differentiation and function. Annu. Rev. Immunol. 30: 531-564.